scispace - formally typeset
P

Patrick Nataf

Researcher at University of Paris

Publications -  19
Citations -  4409

Patrick Nataf is an academic researcher from University of Paris. The author has contributed to research in topics: Extracorporeal membrane oxygenation & Aortic aneurysm. The author has an hindex of 11, co-authored 19 publications receiving 4221 citations. Previous affiliations of Patrick Nataf include Claude Bernard University Lyon 1.

Papers
More filters
Journal ArticleDOI

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.

Guillaume Lebreton, +176 more
TL;DR: In this article, the authors present an analysis of all adult patients with laboratory-confirmed SARS-CoV-2 infection and severe acute respiratory distress syndrome (ARDS) requiring ECMO who were admitted to 17 Greater Paris intensive care units between March 8 and June 3, 2020.
Journal ArticleDOI

Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients.

TL;DR: This observational study suggests that LRA was associated with less intraoperative hemodynamic instability and significant shortening of the procedure and hospital stay and changes in the anesthetic technique adapted to changes in TAVI interventional techniques and did not increase the rate of postoperative complications.
Journal ArticleDOI

Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly.

TL;DR: A large proportion of elderly patients referred for management of severe AS have a high-risk profile, and the availability of percutaneous valvular interventions increases the number of those who are offered interventions.
Journal ArticleDOI

Transfemoral Implantation of Transcatheter Heart Valves After Deterioration of Mitral Bioprosthesis or Previous Ring Annuloplasty

TL;DR: This single-center series suggests that transfemoral THV implantation for deterioration of mitral bioprosthesis or surgical repair is feasible in selected patients and improves early hemodynamic and midterm functional status.